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location, and extent of disease involvement. It is also a
means of assessing the adequacy of stent deployment and
provides the measurement information necessary for com-
plete expansion of a stent to ensure its full apposition to
the arterial wall.6-8 Earlier studies have shown that arteri-
ography, when compared with IVUS, fails to provide accu-
rate information about stent deployment in as many as
40% of iliac arteries treated with balloon angioplasty and
stenting.9-14
The purpose of this study was to determine whether
the use of IVUS influenced the long-term patency of aor-
toiliac occlusive lesions treated with balloon angioplasty
and primary stenting.
METHODS
Patients. Between March 1992 and October 1995,
71 consecutive limbs (52 patients) with aortoiliac occlu-
sive disease underwent balloon angioplasty and primary
stenting of symptomatic iliac lesions at a single center
multi-specialty clinic. All patients were entered prospec-
tively in a vascular registry, and their clinical course and
outcomes were retrospectively reviewed. In 1998, we
reported initial and intermediate results (mean, 28
months), which suggested that those patients whose iliac
Intravascular stents are used as a means of improving
the patency of arterial occlusive lesions that have under-
gone treatment with balloon angioplasty by reducing the
incidence of technical failure and restenosis.1,2 Under-
deployment of an intravascular stent has been identified as
a cause of restenosis or occlusion of a treated arterial
lesion.3 Intravascular ultrasound scanning (IVUS) is a
catheter-delivered imaging system that provides an accu-
rate measurement of the diameter of both diseased and
true lumens of arteries.4,5 It can be used as a means of
evaluating plaque morphology and structural information
related to the arterial wall for calcification, branch vessel
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Purpose: Underdeployment of an intravascular stent has been identified as a cause of restenosis or occlusion of a treated
arterial lesion. Intravascular ultrasound (IVUS) has been shown to initially improve the anatomic and clinical stenting.
The purpose of this study was to determine whether the use of IVUS increased long-term patency of this intervention.
Methods: Between March 1992 and October 1995, 71 limbs (52 patients) with symptomatic aortoiliac occlusive disease
underwent balloon angioplasty with primary stenting. IVUS and arteriography were used in 49 limbs (36 patients) to
evaluate stent deployment. Arteriography alone was used in 22 limbs (16 patients) to evaluate stent deployment.
Patients were captured prospectively in a vascular registry and retrospectively reviewed.
Results: Mean age of patients treated with IVUS was 61.1 ± 9.0 years (range, 38-85) versus 70.0 ± 10.1 years (range,
57-87) in patients treated without IVUS (P < .01). There was no difference between the groups with respect to pre-
operative comorbidities, ankle-brachial indices, or number of stents per limb. Mean follow-up for IVUS patients was
62.1 ± 7.3 months (range, 15-81) and 57.9 ± 8.7 months (range, 8-80) for patients treated without IVUS (P = not
significant). In 40% (20/49) of limbs, IVUS demonstrated inadequate stent deployment at the time of the original pro-
cedure. Kaplan-Meier 3- and 6-year primary patency estimates were 100% and 100% in the IVUS group and 82% and
69%, respectively, in limbs treated without IVUS (P < .001). There have been no secondary procedures performed in
limbs treated with IVUS and a 23% (5/22) secondary intervention rate in the non-IVUS group (P < .05). Overall
Kaplan-Meier survival estimates at 3 and 6 years for all patients were 84% and 67%, respectively.
Conclusion: Balloon angioplasty and primary stenting of symptomatic aortoiliac occlusive lesions is a durable treatment
option. Long-term follow-up of treated patients shows outcomes that are comparable with direct surgical intervention.
IVUS significantly improved the long-term patency of iliac arterial lesions treated with balloon angioplasty and stent-
ing by defining the appropriate angioplasty diameter endpoint and adequacy of stent deployment. (J Vasc Surg
2002;35:316-23.)
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arterial occlusive lesions were evaluated with IVUS at the
time of endovascular treatment had improved out-
comes.3,10 All patients have been observed in the long
term and serve as the cohort for this report. IVUS and
arteriography were used in 49 limbs, and arteriography
alone was used in 22 limbs as a means of evaluating stent
deployment.
The indications for treatment were categorized with
classifications suggested by Rutherford et al15 and
included disabling claudication in 59.6% of cases, ischemic
rest pain in 26.9% of cases, and tissue loss in 13.4% of
cases. Subjects were examined before treatment by using
both noninvasive lower-extremity arterial testing and arte-
riography.
Operative technique. We have described in detail the
equipment and techniques used for treating the 52
patients in this ongoing study.3 All patients were pre-
treated with at least 162 mg of aspirin preoperatively and
underwent systemic anticoagulation with heparin intraop-
eratively to achieve an activated clotting time (ACT) of
two times normal. Iliac occlusive lesions were treated with
balloon angioplasty and primary stenting by using Palmaz
balloon expandable stents (Johnson & Johnson Inter-
national Systems, Warren, NJ). Most procedures (67/71
limbs) were performed with an open femoral artery expo-
sure technique. Associated femoral arterial occlusive
lesions (15/67 limbs) were managed by means of direct
surgical repair (endarterectomy, patch angioplasty) at the
time of the endovascular intervention. Treated lesions
included 64 limbs with hemodynamically significant
stenoses (resting systolic pressure gradient >20 mm Hg)
and seven total iliac occlusions.3
IVUS and arteriography were used as a means of eval-
uating iliac artery diameter and stent deployment in 49
treated limbs. A 20-MHz or 30-MHz ultrasound trans-
ducer (Hewlett-Packard Sonos Intravascular, Andover,
Md) was used as a means of imaging the vessel. IVUS
measurement of actual vessel diameter was used as a means
of determining the size of the angioplasty balloon catheter
and stent. A stent was considered underdeployed when
any part of the stent was not in complete apposition to the
arterial wall. Underdeployed stents identified by means of
IVUS underwent further expansion with a larger angio-
plasty balloon until complete stent-to-vessel wall apposi-
tion occurred. Pull down pressure measurements were
made across each treated lesion in both the IVUS plus
arteriography group and the arteriography alone group.
In the 22 limbs evaluated by means of arteriography
alone, angioplasty balloon diameter and stent size used for
treatment of the occlusive lesion were derived from diam-
eter measurements of the non-stenosed segment of either
the ipsilateral or contralateral iliac artery. The measure-
ments were made in a “normal” vessel either proximal
(preferably) or distal to the lesion identified for treatment.
The use of the distal measurement was avoided whenever
possible to exclude the post-stenotic dilatation effect. 
Postoperatively, all patients received 162 mg of aspirin
and 150 mg of dipyridamole daily, which was continued
indefinitely. Those patients (7 in the IVUS plus arteriog-
raphy group and 2 in the arteriography alone group) who
had their distal abdominal aorta and common iliac arteries
reconstructed with bilateral stents by using the “kissing
balloon” technique and whose stents were in apposition at
the aortic bifurcation underwent anticoagulation with
Coumadin (international normalized ratio, 2.0-2.5) for a
period of 3 to 6 months.
Postoperative surveillance. The preprocedural and
postprocedural clinical records, arteriograms, segmental
limb pressure measurements, and pulse volume recordings
of all patients were retrospectively reviewed. Postoperative
follow-up of all patients included clinical examination and
noninvasive lower-extremity vascular testing at 3, 6, and
12 weeks and at 6-month intervals thereafter. Noninvasive
lower-extremity vascular testing consisted of segmental
Fig 1. Kaplan-Meier estimates of vessel patency for both the group of limbs evaluated with IVUS and the
group of limbs not evaluated with IVUS.
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systolic limb blood pressure measurements, segmental air
plethysmographic recordings (pulse volume recordings),
and selective use of Doppler waveform evaluation. Duplex
imaging was used when necessary as a means of evaluating
stent patency and measuring flow velocities. Repeat arteri-
ography was used when indicated by means of abnormal
clinical information (severe claudication or ischemic rest
pain) or noninvasive vascular testing. Abnormal vascular
testing was defined as a 30 mm Hg or greater segmental
systolic pressure drop across the treated lesion or signifi-
cant deterioration (category change) in pulse volume
recordings in the affected limb.
The limitations of clinical and noninvasive follow-up as
a means of evaluating endovascular procedures on the iliac
arteries required that each intervention be assessed on a
per-limb basis by using several hemodynamic and clinical
criteria. Each limb was observed from the time of the ini-
tial procedure to the time of a second intervention on that
limb or to the time of last follow-up. Secondary interven-
tions were subjected to the same follow-up protocol that
was used for primary interventions. Determinations of suc-
cess and failure were made on the basis of the suggested
standards for reports that deal with lower-extremity
ischemia.15-18
Statistical analysis. All averages are given as the
mean plus or minus the SEM. Age, number of stents
deployed per limb, preoperative ankle-brachial indices
(ABIs), and postoperative ABIs were analyzed by using
the two-sample t test. Other variables, including demo-
graphics, complications, restenosis, morbidity, and mortal-
ity, were evaluated by using the Fisher exact test.
Kaplan-Meier estimates were used as a means of evaluating
patency and survival. P values less than .05 indicated sta-
tistical significance.
RESULTS
The mean age of patients who were examined with
IVUS plus arteriography was 61.1 ± 9.0 years (range, 38-
85 years) versus 70.0 ± 10.1 years (range, 57-87 years) for
patients examined with arteriography alone (P < .01;
Table I). There were no statistical differences noted
between the two treatment groups in the presence of
comorbidities, including coronary artery disease, diabetes
mellitus, chronic obstructive pulmonary disease, hyperten-
sion, obesity, or length of follow-up. Also, the number of
stents used per limb and the preoperative and immediate
postoperative lower-extremity arterial testing results were
comparable in both groups (Table II).
In the IVUS plus arteriography group, the anatomic
site of the treated atherosclerotic lesion was the common
iliac artery in 35 limbs (72.2%), the external iliac artery in
eight limbs (16.6%), and a combination of the common
and external iliac arteries in six limbs (11.1%). There were
seven recanalized total iliac arterial occlusions in this
group. The ipsilateral superficial femoral artery was docu-
mented by means of arteriographic examination to be
widely patent or bypass grafted in 35 limbs (72.2%),
stenotic in six limbs (12.2%), and occluded in eight limbs
(16.6%).
In the 22 limbs evaluated with arteriography alone,
the common iliac artery was treated in 18 limbs (81.2%)
and the external iliac artery in four limbs (18.8%). There
were no iliac artery occlusions in this group. The ipsilat-
eral superficial femoral artery was documented by means
of arteriographic examination to be patent in 18 limbs
(81.2%), stenotic in three limbs (12.5%), and occluded in
one limb (6.2%).
Forty percent (20/49) of limbs were found to have
underdeployed stents by means of IVUS evaluation,
although they appeared to be adequately expanded by
means of arteriography. Further stent expansion with a
larger balloon was necessary for accurate stent-to-vessel wall
apposition. After the procedure, pull down pressure mea-
surements were made across the treated lesions, and no gra-
dient was accepted in either group of patients. Completion
arteriography was also accomplished at that time.
Fig 2. Kaplan-Meier estimates of vessel patency for all limbs studied.
Associated significant occlusive lesions in the common
femoral, proximal profunda, and/or superficial femoral
arteries were managed at completion of the endovascular
procedure with localized endarterectomy and patch angio-
plasty repairs. The adjunctive procedures were necessary in
22.4% (11/49) of limbs in the IVUS plus arteriography
group and 22.7% (5/22) of limbs in the arteriography
alone group (P = not significant; Table III). 
Long-term follow-up of patients. Complete long-
term clinical follow-up was available for 50 of 52 patients
(96%). A mean follow-up period of 62.1 ± 7.3 months
(range, 15-81 months) was achieved for the IVUS plus
arteriography group. The mean follow-up for patients
examined and treated with arteriography alone was 57.9 ±
8.7 months (range, 8-80 months; P = not significant).
Patients examined with intravascular ultrasound
scanning. There were no restenoses or occlusions in the
IVUS plus arteriography group, as measured indirectly by
using the criteria outlined by Ahn et al.18 A sustained
improvement in the ABI was documented in all 49 limbs
at the time of last follow-up. The mean ABI improvement
was 0.39 from the preoperative measurement (P <
.000001). Kaplan-Meier 3-year and 6-year primary
patency estimates were 100% and 100%, respectively, in
the IVUS plus arteriography group (Fig 1). No limbs in
the IVUS plus arteriography group underwent repeat
arteriographic examination because of suspected resteno-
sis or occlusion of the treated lesion. However, eight
patients underwent either coronary or cerebral arteriogra-
phy and had incidental arteriographic evaluation of the
earlier balloon-dilated and stented iliac lesions that were
found to be patent.
Patients examined with arteriography alone.
Seventeen of 22 limbs (11/16 patients) evaluated and
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treated with arteriography alone had a sustained mean
ABI improvement of 0.37 from the preoperative measure-
ment to that taken 3 years after their primary intervention
(P < .000001). Kaplan-Meier 3-year and 6-year primary
patency rate estimates were 82% and 69%, respectively. 
Early restenosis or occlusion of stented lesions occurred
in 18% (4/22) of limbs evaluated and treated with arteri-
ography alone (P < .01) after a mean follow-up period of
5.5 months (range, 4 to 7 months). These early failures
were evaluated indirectly by means of criteria outlined by
Ahn et al.18 Severe restenoses (2 patients) and occlusions (2
patients) at the site of the earlier stented lesions were docu-
mented by means of subsequent arteriographic and IVUS
evaluations. Underdeployed stents were demonstrated by
means of IVUS in all four cases. Femoral artery outflow was
not considered to be a factor in these four failures because
the superficial femoral artery was widely patent in three
limbs and occluded at the adductor canal in the fourth case.
This latter case had a large widely patent profunda femoris
artery. Additional endovascular intervention was necessary
to salvage these reconstructions. They remained patent
through their last follow-up evaluation.
Two late failures occurred in the group treated with
arteriography alone. One of these failures was docu-
mented by means of arteriography to be related to occlu-
sive disease progression in the treated limb, including the
earlier balloon-dilated and stented common and proximal
external iliac arteries. This patient was treated with stan-
dard prosthetic aortobifemoral arterial bypass grafting
surgery, and this reconstruction remained patent until the
patient’s death 2 years later. The second late failure was
not evaluated by means of arteriography because of the
patient’s other comorbid conditions, which precluded
consideration for intervention. An above-knee amputation
Table I. Demographics
Without IVUS (%) With IVUS (%) P value
Number of limbs 22 49
Mean age (y; range) 70 ± 10 (57-87) 61 ± 9 (38-85) < .01
Comorbidities
CAD 22 (100) 44 (89) .30
Chronic tobacco use 19 (88) 44 (89) 1.00
COPD 15 (69) 41 (83) .28
Diabetes mellitus 11 (50) 12 (25) .11
Obesity 3 (13) 5 (11) 1.00
IVUS, Intravascular ultrasound scanning; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease.
Table II. Treatment comparisons
Without IVUS (range) With IVUS (range) P value
Number of limbs 22 49
Preoperative ABI 0.44 ± 0.12 0.43 ± 0.16 .91
Immediate postoperative ABI 0.81 ± 0.14 0.82 ± 0.15 .90
Mean number of stents used 1.7 ± 1.0 (1-3) 1.8 ± 1.2 (1-3) .46
IVUS, Intravascular ultrasound scanning; ABI, ankle-brachial index.
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was performed in this patient. There were no secondary
procedures performed in limbs evaluated and treated with
IVUS plus arteriography. This contrasts with a secondary
intervention rate in the arteriography alone group of 23%
(5/22 limbs; P < .05). The overall patency rate for the 71
limbs, by means of Kaplan-Meier estimates, in this study
was 94% at 6 years (Fig 2).
Perioperative morbidity and mortality. Perioperative
complications occurred in four of 52 patients (7%). A severe
myocardial infarction resulted in death within 30 days of
operation in a patient examined and treated with arteriog-
raphy alone (2% overall mortality rate for the whole series).
One vessel perforation in the IVUS-assisted group occurred
during angioplasty of a heavily calcified vessel and required
direct surgical repair. This vessel perforation occurred dur-
ing the balloon dilatation before stent deployment. The ini-
tial balloon size was determined by means of angiographic
criteria, and as a result, the complication could not be
related to the use of either the stent or IVUS. One groin
hematoma occurred in both groups, and one lymphocele
developed in the IVUS-assisted group. These were treated
conservatively. No statistical difference was noted in the
complication rates in the two groups.
Survival analysis. Overall Kaplan-Meier survival esti-
mates for this group of patients with significant aortoiliac
occlusive disease were 84% at 3 years and 67% at 6 years
(Fig 3). Late cardiac events accounted for mortality in 68%
of the patients who died.
DISCUSSION
Intravascular stents are used as a means of improving
the results of balloon angioplasty by compressing dis-
rupted atheroma, intima, and media against the vessel wall
and thereby maintaining the integrity of the balloon-
dilated arterial lumen. Balloon angioplasty and stenting of
aortoiliac occlusive lesions is an acceptable course of man-
agement for this disease process. Five-year patency rates
for balloon angioplasty of iliac occlusive lesions range from
59% to 87% in several reported series.19-22 When endolu-
minal stenting is added to the angioplasty procedure,
patency rates from 63% to 100% have been reported by
recent studies, with follow-up periods ranging from 2 to 6
years. However, several of these studies had inadequate
follow-up and surveillance of these patients.23-25
The strength of our study is the very close vascular
surgery follow-up of 71 consecutive limbs treated with
balloon angioplasty and primary stenting of symptomatic
iliac occlusive lesions. The patients in this study received
continuous care in a multi-specialty clinic environment,
and 96% of their treated limbs had complete vascular fol-
low-up at a mean of 5 years.
Arteriography has historically been the standard means
of evaluating endovascular treatment and delineating the
severity and extent of arterial occlusive disease. Arterio-
graphy visualizes contrast within the lumen of a vessel and
presents a two-dimensional representation of a three-
Fig 3. Kaplan-Meier estimates of patient survival.
Table III. Adjunctive femoral artery procedures
Without IVUS With IVUS
Adjunctive procedure 5/22 limbs (22.7%) 11/49 limbs (22.4%)
Common femoral endarterectomy and patch angioplasty 1 4
Common femoral/profunda femoral endarterectomy and patch angioplasty 3 5
Common femoral/proximal SFA endarterectomy and patch angioplasty 1 2
IVUS, Intravascular ultrasound scanning; SFA, superficial femoral artery.
dimensional structure. In some circumstances, heavy ves-
sel wall calcification can be identified at the time of arteri-
ography. No information about plaque morphology or
true non-diseased vessel diameter can be obtained by
means of conventional arteriographic techniques. Because
of magnification and imaging angle, the actual severity of
an arterial lesion may be misrepresented.26
Multiplane arteriographic views would be required to
adequately evaluate the degree of stenosis at any given
lesion site, because most atherosclerotic lesions are eccen-
trically located within the vessel.
The real time 360° cross-sectional imaging of an
artery provided with IVUS permits an accurate measure-
ment of both diseased and true lumen diameters of vessels,
defines the composition and extent of occlusive lesions,
and accurately assesses the results of an endovascular inter-
vention.6-8,10-14,27 Arteriography has been shown to
underestimate the true diameter of the vessel as much as
50% of the time.3 Incomplete apposition of a stent to the
arterial wall was not detected by means of arteriography in
20% to 40% of patients subsequently examined with
IVUS.3,9,10 Another study using IVUS in the coronary
circulation showed that 80% of stents needed further bal-
loon expansion for complete vessel wall apposition,
although their deployment was thought to be optimal by
means of coronary arteriographic assessment.28 In our
study, IVUS was used as a means of measuring the true
arterial lumen diameter, and this information influenced
the selection of the size of the angioplasty balloon and
stent used to treat the occlusive lesion. It was also used as
a means of determining the adequacy of apposition of a
deployed stent to the vessel wall and identifying any com-
plications that might require additional treatment (dissec-
tion, etc). Inadequate vessel dilatation and incomplete
stent deployment have been identified as suspected causes
for restenosis or occlusion of treated lesions.3 Incomplete
apposition of a stent to the arterial wall leaves a space
where platelets, fibrin, and thrombus accumulate. If this
area is in contact with fractured intima and/or media of
the vessel wall, we postulate that it may serve as a nidus for
initiating the restenotic process.
It has been suggested that over-dilatation of a balloon-
dilated and stented lesion could be used in place of IVUS
guidance as a means of obtaining complete stent-to-vessel
wall apposition.26 However, angioplasty over dilatation
runs the risk of vessel disruption, especially in heavily cal-
cified vessels or moderately diseased external iliac arteries.
Additionally, despite satisfactory coronary arteriographic
findings, Columbo and associates found that after rou-
tinely over-dilating stented coronary lesions, in approxi-
mately 30% of cases, stents were shown by means of
subsequent IVUS evaluation to still be underdeployed or
other procedure-related problems were identified that
required additional treatment.28,29
The weaknesses of this study are that it is retrospec-
tive, that it has fewer numbers of limbs in the group exam-
ined by arteriography alone, and that all procedures were
done with an open femoral artery exposure technique.
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Also, a statistically significant younger population com-
prised the IVUS plus arteriography group. Sullivan et al30
reported that age can be associated with initial and late
failure of iliac artery angioplasty and primary stenting, and
therefore, the age difference in the two groups may have
had some effect on outcome.
Other than the difference in age, the treated lesions
and extent of occlusive disease in the two groups were
comparable. Furthermore, the IVUS plus arteriography
group had seven limbs with complete iliac arterial occlu-
sion and six limbs with common and external iliac artery
lesions that required treatment. This implies that these 13
limbs had more severe disease involvement, yet all have
remained patent to date.
Ipsilateral superficial femoral artery patency has been
described as a factor contributing to the long-term results
of iliac arterial angioplasty and stenting.15-17 Sullivan et
al30 found a positive correlation between superficial
femoral artery patency and the patency of ipsilateral bal-
loon-dilated and stented iliac lesions. In our study, the
superficial femoral artery was patent or bypass grafted in
35 limbs (72%) in the IVUS plus arteriography group and
in 18 limbs (81.2%) in the group evaluated with arteriog-
raphy alone. The superficial femoral artery was considered
to be stenotic in six limbs (12.2%) in the IVUS plus arte-
riography group and in three limbs (12.5%) in the group
evaluated with arteriography alone. These data suggest
that femoral artery outflow for both groups was compara-
ble. The IVUS group did have more occluded superficial
femoral arteries (8 limbs, 16.6%) compared with the arte-
riography alone group (1 limb, 6.2%). This suggests that
limbs in the IVUS group may have had more diffuse
occlusive disease. However, because most procedures were
performed through open exposure of the femoral artery,
any associated occlusive lesions in the common femoral,
proximal profunda femoral, and/or superficial femoral
arteries were managed at the time of the endovascular pro-
cedure by using endarterectomy and patch angioplasty
repair. The percentage of cases requiring this type of inter-
vention was similar in both the IVUS and non-IVUS
assisted groups (22.4% vs 22.7%).
We have been reluctant to conduct a randomized
prospective study with and without IVUS assistance for
balloon angioplasty and stenting of iliac arterial occlusive
lesions. Our experience, like that of other authors
reported for both the coronary and peripheral circulation,
shows that IVUS provides very useful information that
influences the treatment process. In our opinion, not
using IVUS for angioplasty and stenting procedures
would put some of those patients randomized to a non-
IVUS evaluation group at a disadvantage. 
The use of IVUS adds additional cost to an endovas-
cular procedure. The catheter-delivered transducer used in
this study was disposable and cost approximately $400. An
experienced technician was necessary to operate the IVUS
system, and the system itself costs approximately
$120,000. Our IVUS unit is shared with the Division of
Interventional Cardiology, with approximately one third of
the use attributed to peripheral endovascular procedures.
The financial department of our institution estimates a
cost-per-case for the technician and equipment, exclusive
of the disposable transducer, to be approximately $680.
The combined added cost-per-case for IVUS would then
equal $1080. The use of IVUS is reimbursed through a
specific current procedural terminology code. This reim-
bursement is less than the cost of the disposable catheter-
delivered transducer. However, the expense associated with
the salvage of an endovascular intervention once it has
failed is estimated to be approximately $12,000 to $15,000
in our institution. In this series, if the use of IVUS had sal-
vaged the four early failures at the time of initial treatment,
it would have paid for its use in all 52 patients.
Aortofemoral prosthetic bypass grafting procedures
have produced excellent long-term results for the manage-
ment of aortoiliac occlusive disease, with an anticipated 3%
per year failure rate. Unfortunately, this procedure has 1%
to 5% perioperative mortality rates and 10% to 15% mor-
bidity rates. Extra-anatomic bypass grafting procedures
(axilofemoral or femoral-femoral) have lower mortality and
morbidity rates, but may also have decreased durability. In
comparison, the long-term patency rate of balloon-dilated
and stented iliac artery occlusive lesions in our series has
been excellent (94% at 60 months). Those limbs evaluated
with IVUS had a 100% patency rate during follow-up eval-
uations, and even those limbs treated without the use of
IVUS had an 82% patency rate at 5 years. Failures that
occurred in the arteriography alone group were related to
inadequate stent deployment and occurred early (<12
months after initial treatment). These were salvaged by
using endovascular techniques. They subsequently
remained patent for the duration of their follow-up. Our
results are comparable with those of direct surgical inter-
vention and have lower mortality and morbidity rates.
The patient survival rate in our study group was found
to be 84% at 3 years and 67% at 6 years by using Kaplan-
Meier survival estimates. As expected, cardiac events were
responsible for 68% of the mortality. Survival results are
similar to the earlier reported 28% 5-year mortality rate in
patients with lower-extremity peripheral arterial disease.31
CONCLUSION
The use of IVUS as a means of defining the appropri-
ate arterial diameter for an angioplasty procedure and
assessing adequacy of stent deployment must be consid-
ered to be a factor for improving the long-term patency of
iliac arterial occlusive lesions treated with balloon angio-
plasty and stenting.
We thank Mark Riggs, PhD, Director of Biostatistics
at Scott & White Hospital, who performed the statistical
analysis on the data for this study.
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Dr Murray Shames (St Louis, Mo). Would the use of self-
expanded stents have eliminated the problem with underexpan-
sion using balloon-expandable stents?
Dr Clifford Buckley. We have not used many self-expanding
stents. All of the stents used in the study were balloon expand-
able. I have not had the opportunity to interrogate many self-
expanding stents with IVUS. Of those that I have studied with
IVUS, the majority were not completely in apposition with the
vessel wall at all locations. Self-expanding stents are usually lim-
ited in their degree of expansion by the narrowest part of the ves-
sel which comes in circumferential contact with the stent wall.
You still have the problem of inadequate stent apposition to
the wall if the wall has not been fully dilated so that the stent is
able to embed itself against the wall.
Dr Takao Ohki (Bronx, NY). For the purpose of this analysis,
I think you should eliminate the two late failures encountered in
the non-IVUS group that were secondary from progression of
disease, because that has nothing to do with whether one used
IVUS or not. So you basically have four occlusions for the non-
IVUS group and zero for the other, which kind of minimizes the
difference between the two groups.
I do agree with basically all of your comments, except that
you’re recommending routine use for every single case. I think
you can reduce the number of IVUS needed by doing careful aor-
togram, completion angiogram with biplane projection, and also
with the use of pressure gradient pull-through method. By com-
bining the methods, I think you can selectively use IVUS and still
maintain the benefit that you’re talking about. Can you comment
on that approach?
Dr Buckley. What you say may be true. However, arteriogra-
phy can fail to identify areas of dissection and it will not show you
incomplete apposition of stent to the vessel wall in approximately
40% to 50% of cases. Also, IVUS gives the best measurement of
true vessel lumen diameter so that you can size dilating balloons
and stents accurately and avoid under-dilatation or over-dilatation
and potential vessel rupture.
DISCUSSION
